Angiotensin-(1-7): An update

Regulatory Peptides

Volumn 91, Issue 1-3, 2000, Pages 45-62

  Santos, Robson A S ^a   Campagnole Santos, Maria J ^a   Andrade, Sílvia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin (1 7); Multiple mediator system; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; A 779; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 THREONINE]; ANGIOTENSIN[1-7]; APROTININ; CANDESARTAN; CARBOXYPEPTIDASE B; ENALAPRILAT; ICATIBANT; INDOMETACIN; IRBESARTAN; LISINOPRIL; LOSARTAN; MECLOFENAMIC ACID; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; RAMIPRILAT; SARALASIN; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; CENTRAL NERVOUS SYSTEM; ELECTROLYTE BALANCE; HEART; HUMAN; KIDNEY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; CENTRAL NERVOUS SYSTEM; HUMANS; KIDNEY; LOSARTAN; MODELS, BIOLOGICAL; MYOCARDIUM; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTEIN BINDING; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 0034725602     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(00)00138-5     Document Type: Review

References (230)

1. Brunner H.R., Laragh J.H., Baer L., Newton M.A., Goodwin F.T., Krakoff L.R., Bard R.H., Buhler F.R. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 286:(9):1972;441-449.
2. Page I.H., Bumpus F.M. Angiotensins. 1974;Springer-Verlag, New York.
3. Peach M. Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev. 57:1977;313-370.
4. Haber E., Carlson W. The biochemistry of the renin-angiotensin system. Genest J., Kuchel O., Hamet P., Cantin M. Hypertension. Physiopathology and treatment. 1983;171-184 McGraw-Hill, New York.
5. Phillips M.I., Weyhenmeyer J.A., Felix D., Ganten D. Evidence for an endogenous brain renin-angiotensin system. Fed Proc. 38:1979;2260-2266.
6. Dzau V.J. Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control. J Hypertens. 6:(Suppl 3):1988;S7-S12.
7. Phillips M.I., Speakman E.A., Kimura B. Levels of angiotensin and molecular biology of the tissue renin-angiotensin systems. Regul Pept. 43:1992;1-20.
8. Wollert K.C., Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res. 43:1999;838-849.
9. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., Bernstein K.E. Isolation of a c-DNA encoding the vascular type-1 angiotensin II receptor. Nature. 351:1991;233-236.
10. Furuta H., Guo D.F., Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun. 183:1992;8-13.
11. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R.E., Dzau V.J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 268:1993;24539-24542.
12. Kambaiashi Y., Bardhan S., Takahashi K., Tsuzuki S., Inui H., Hamakubo T., Inagami T. Molecular cloning of a novel angiotensin II isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem. 268:1993;24543-24546.
13. Inagami T. Molecular biology and signaling of angiotensin receptors: an overview. J Am Soc Nephrol. 10:1999;S2-S7.
14. Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol. 10:1999;S30-S39.
15. Wright J.W., Harding J.W. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Rev. 17:1992;227-262.
16. Griendling K.K., Lassègue B., Alexander W. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol. 36:1996;281-306.
17. Baltatu O., Bader M., Ganten D. Functional testing of components of the brain renin-angiotensin system in transgenic animals. Ulfendahl H., Aurell M. Renin-angiotensin. 1998;105-114 Portland Press, London.
18. Phillips M.I., Sumners C. Angiotensin II in central nervous system physiology. Regul Pept. 78:1998;1-11.
19. Ferrario C.M., Chappell M.C., Dean R.H., Iyer S.N. Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis. J Am Soc Nephrol. 9:1998;1716-1722.
20. Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 52:(1):2000;11-34.
21. Santos R.A.S., Campagnole-Santos M.J. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res. 27:1994;1033-1047.
22. Lynch D.R., Snyder S.H. Neuropeptides: multiple molecular forms, metabolic pathways, and receptors. Annu Rev Biochem. 55:1986;773-799.
23. Maggio J.E. Tachykinins. Annu Rev Neurosci. 11:1988;13-28.
24. Margolius H.S. Kallikreins and kinins - some unanswered questions about system characteristics and roles in human disease. Hypertension. 26:1995;221-229.
25. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 44:1992;1-80.
26. Reijmers L.G., van Ree J.M., Spruijt B.M., Burbach J.P., De Wied D. Vasopressin metabolites: a link between vasopressin and memory? Prog Brain Res. 119:1998;523-535.
27. Gutkowska J., Antunes-Rodrigues J., McCann S.M. Atrial natriuretic peptide in brain and pituitary gland. Physiol Rev. 77:(2):1997;465-515.
28. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int. 49:1996;1732-1737.
29. Stjernquist M. Endothelins - vasoactive peptides and growth factors. Cell Tissue Res. 292:1998;1-9.
30. Ferrario C.M., Chappell M.C., Tallant E.A., Brosnihan K.B., Diz D.I. Counterregulatory actions of angiotensin-(1-7). Hypertension. 30:(2):1997;535-541.
31. Linz W., Wohlfart P., Bernward A., Schölkens A., Malinski T., Wiemer G. Interactions among ACE, kinins and NO. Cardiovasc Res. 43:1999;549-561.
32. Luft F.C. Meet the 'other' angiotensins. J Mol Med. 75:(3):1997;157-159.
33. Ardaillou R. Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects. Curr Opin Nephrol Hypertens. 6:(1):1997;28-34.
34. Tallant E.A., Diz D.I., Ferrario C.M. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension. 34:(2):1999;950-957.
35. 4 receptor system. Am J Physiol. 277:(1):1999;F75-F83.
36. Braszko J.J., Wlasienko J., Koziolkiewicz W., Janecka A., Wisniewski K. The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties. Brain Res. 554:1991;49-54.
37. Brosnihan K.B., Li P., Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 27:1996;523-528.
38. Paula R.D., Lima C.V., Britto R.R., Campagnole-Santos M.J., Khosla M.C., Santos R.A.S. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides. Peptides. 20:1999;493-500.
39. Johnson A.R., Erdös E.G. Metabolism of vasoactive peptides by human endothelial cells in culture: angiotensin I converting enzyme (kininase II) and angiotensinase. J Clin Invest. 59:1977;684-695.
40. Santos R.A.S., Brosnihan K.B., Chappell M.C., Pesquero J.L., Chernicky C.L., Greene L.J., Ferrario C.M. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension. 11:1988;153-157.
41. Chappell M.C., Brosnihan K.B., Diz D.I., Ferrario C.M. Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem. 264:(28):1989;16518-16523.
42. Chappell M.C., Tallant E.A., Brosnihan K.B., Ferrario C.M. Processing of angiotensin peptides by NG108-15 neuroblastoma×glioma hybrid cell line. Peptides. 22:1990;375-380.
43. Campbell D.J., Lawrence A.C., Towrie A., Kladis A., Valentijn A.J. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension. 18:1991;763-773.
44. Welches W.R., Santos R.A.S., Chappell M.C., Brosnihan K.B., Greene L.J., Ferrario C.M. Prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertension. 9:1991;631-638.
45. Santos R.A.S., Brosnihan K.B., Jacobsen D.W., DiCorleto P.E., Ferrario C.M. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension. 19:(Suppl II):1992;II56-II61.
46. Yamamoto K., Chappell K., Brosnihan K.B., Ferrario C.M. In vivo metabolism of angiotensin I by neutral endopeptidase (EC3.4.24.11) in spontaneously hypertensive rats. Hypertension. 19:1992;1201-1211.
47. Kohara K., Brosnihan K.B., Ferrario C.M. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides. 11:1993;883-891.
48. Ferrario C.M., Chappell M.C. A new myocardial conversion of angiotensin I. Curr Opin Cardiol. 9:(5):1994;520-526.
49. Neves L.A.A., Almeida A.P., Khosla M.C., Santos R.A.S. Metabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors. Biochem Pharmacol. 50:(9):1995;1451-1459.
50. Campbell D.J., Duncan A.M., Kladis A., Harrap S.B. Angiotensin peptides in spontaneously hypertensive and normotensive donryu rats. Hypertension. 25:1995;928-934.
51. Yamada K., Iyer S.N., Chappel M.C., Ganten D., Ferrario C.M. Converting enzyme determines the plasma clearance of angiotensin-(1-7). Hypertension. 98:1998;496-502.
52. Chappell M.C., Gomez M.N., Pirro N.T., Ferrario C.M. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension. 35:(2):2000;348-352.
53. Lawrence A.C., Evin G., Kladis A., Campbell D.J. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens. 8:1990;715-724.
54. Greene L.J., Spadaro A.C.C., Martins A.R., Perussi de Jesus W.D., Camargo A.C.M. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II. Hypertension. 4:1982;178-184.
55. Snyder R.A., Watt K.W.K., Wintroub B.U. A human platelet angiotensin I-processing system: identification of components and inhibition of angiotensin-converting enzyme by product. J Biol Chem. 260:1985;7857-7860.
56. 2 receptor. Hypertension. 33:1999;835-843.
57. Orlowski M., Wilk E., Pearce S., Wilk S. Purification and properties of a prolyl endopeptidase from rabbit brain. J Neurochem. 33:1979;461-469.
58. Tan F., Morris P.W., Skidgel R.A., Erdos E.G. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C): similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem. 268:1993;16631-16638.
59. Iyer S.N., Ferrario C.M., Chappell M.C. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension. 31:(2):1998;356-361.
60. Chappell M.C., Pirro N.T., Sykes A., Ferrario C.M. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 31:(2):1998;362-367.
61. Deddish P.A., Marcic B., Jackman H.L., Wang H.Z., Skidgel A.R., Erdos E.G. N-domain specific substrate and c-domain inhibition of angiotensin-converting enzyme: angiotensin-(1-7) and Keto-ACE. Hypertension. 31:1998;912-917.
62. Kohara K., Brosnihan K.B., Chappell M.C., Khosla M.C., Ferrario C.M. Angiotensin-(1-7): a member of circulating angiotensin peptides. Hypertension. 17:1991;131-138.
63. Luque M., Martin P., Martell N., Fernadez C., Brosnihan K.B., Ferrario C.M. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens. 14:1996;799-805.
64. Yamada K., Iyer S.N., Chappell M.C., Brosnihan K.B., Fukuhara M., Ferrario C.M. Differential response of angiotensin peptides in the urine of hypertensive animals. Regul Pept. 80:1999;57-66.
65. Iyer S.N., Chappell M.C., Averill D.B., Diz D.I., Ferrario C.M. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension. 31:1998;699-705.
66. Fagundes-Moura C.R. Perfil Plasmático de Angiotensinas Durante o Desenvolvimento da Hipertensão Renal Tipo Um-Rim, um Clip em Ratos. Efeito do Tratamento com Losartan. 1997;Universidade Federal de Minas Gerais. Thesis.
67. Schiavone M.T., Santos R.A.S., Brosnihan K.B., Khosla M.C., Ferrario C.M. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA. 85:1988;4095-4098.
68. Ferrario C.M., Milsted A., Santos R.A.S. Renin, converting enzyme and angiotensin peptides: a review. Keane W.F. A focus in the clinical effects of a long-acting ACE inhibitor/hypertension. 1990;1-20 Raven Press, New York.
69. Brosnihan K.B., Santos R.A.S., Block C.H., Schiavone M.T., Welches W.R., Chappell M.C., Khosla M.C., Greene L.J., Ferrario C.M. Biotransformation of angiotensins in the central nervous system. Ther Res. 9:(5):1988;48-59.
70. Simões e Silva A.C., Baracho N.C.V., Passaglio K.T., Santos R.A.S. Renal actions of angiotensin-(1-7). Braz J Med Biol Res. 30:(4):1997;503-513.
71. Chappell M.C., Iyer S.N., Diz D.I., Ferrario C.M. Antihypertensive effects of angiotensin-(1-7). Braz J Med Biol Res. 31:1998;1205-1212.
72. Ferrario C.M., Iyer S.N. Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regul Pept. 78:1998;13-18.
73. Chappell M.C., Diz D.I., Yunis C., Ferrario C.M. Differential actions of angiotensin-(1-7) in the kidney. Kidney Int. 4:1998;S3-S6.
74. Averill D.B., Diz D.I. Angiotensin peptides and the baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull. 51:(2):1999;119-128.
75. Campagnole-Santos M.J., Diz D.I., Santos R.A.S., Khosla M.C., Brosnihan K.B., Ferrario C.M. Cardiovascular effects of angiotensin (1-7) microinjected into the dorsal medulla of rats. Am J Physiol. 257:1989;H324-H329.
76. Silva L.C.S., Fontes M.A.P., Campagnole-Santos M.J., Khosla M.C., Campos R.R. Jr., Guertzenstein P.G., Santos R.A.S. Cardiovascular effects produced by microinjection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla. Brain Res. 613:1993;321-325.
77. Ambühl P., Felix D., Imboden H., Khosla M.C., Ferrario C.M. Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones. Regul Pept. 38:1992;111-120.
78. Diz D.I., Falgui B., Bosch S.M., Westwood B.M., Kent J., Ganten D., Ferrario C.M. Hypothalamic substance P release. Attenuated angiotensin responses in mRen2(27) transgenic rats. Hypertension. 29:(2):1997;510-513.
79. 3H]norepinephrine from rat atria. Hypertension. 24:(4):1994;457-460.
80. Campagnole-Santos M.J., Heringer S.B., Batista E.N., Khosla M.C., Santos R.A.S. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol. 263:(1):1992;R89-R94.
81. Benter I.F., Diz D.I., Ferrario C.M. Cardiovascular actions of angiotensin-(1-7). Peptides. 14:1993;679-684.
82. Dellipizzi A., Hilchley S.D., McGiff J.C., Bell-Quilley C.P. Natriuretic action of angiotensin-(1-7). Br J Pharmacol. 11:(1):1994;1-4.
83. Pörsti I., Bara A.T., Busse R., Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 111:1994;652-654.
84. Moriguchi A., Tallant E.A., Matsumura K., Reilly T.M., Walton H., Ganten D., Ferrario C.M. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 25:1995;1260-1265.
85. Freeman E.J., Chisolm G.M., Ferrario C.M., Tallant E.A. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 28:(1):1996;104-108.
86. Li P., Chappell M.C., Ferrario C.M., Brosnihan K.B. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 29:1997;394-400.
87. Machado R.D.P., Santos R.A.S., Andrade S.P. Opposing actions of angiotensins on angiogenesis. Life Sci. 66:(1):1999;67-76.
88. Kono T., Taniguchi H., Imura H., Oseko F., Khosla M.C. Biological activities of angiotensin II-(1-6) hexapeptide and angiotensin II-(1-7) heptapeptide in man. Life Sci. 38:1986;1515-1519.
89. Fitzsimons J.T. The effect on drinking of peptide precursor and of short chain peptide fragments of angiotensin II injected into the rat diencephalon. J Physiol. 214:1971;295-303.
90. Trachte G.J., Meixner K., Ferrario C.M., Khosla M.C. Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia. Prostaglandins. 39:(4):1990;385-394.
91. Santos R.A.S., Baracho N.C.V. Angiotensin-(1-7) is a potent anti-diuretic peptide in rats. Braz J Med Biol Res. 25:1992;651-654.
92. Mahon J.M., Allen M., Herbert J., Fitzsimons J.T. The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol. Neuroscience. 69:(1):1995;199-208.
93. Muthalif M.M., Benter I.F., Uddin M.R., Harper J.L., Malik K.U. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther. 284:1998;388-398.
94. Gorelik G., Carbini L.A., Scicli A.G. Angiotensin-(1-7) induces bradykinin-mediated relaxation in porcine coronary artery. J Pharmacol Exp Ther. 286:(1):1998;403-410.
95. Fontes M.A.P., Baltatu O., Caligiorne S.M., Ganten D., Bader M., Campagnole-Santos M.J., Santos R.A.S. Angiotensin peptides acting at the rostral ventrolateral medulla contribute to the hypertension of TGR(mRen2)27 transgenic rats. Physiol Gen. 2:2000;137-142.
96. + antiporter in vascular smooth muscle. Hypertension. 27:1996;72-78.
97. Tan L.M., Sim M.K. Actions of angiotensin peptides on the rabbit pulmonary artery. Life Sci. 66:(19):2000;1839-1847.
98. Rowe B.P., Dixon B. Angiotensin III depressor action in the conscious rabbit is blocked by losartan but not PD123319. Hypertension. 35:(1):2000;130-134.
99. Nishimura H., Tsuji H., Masuda H., Kasahara T., Yoshizumi M., Sugano T., Kimura S., Kawano H., Kunieda Y., Yano S., Nakagawa K., Kitamura H., Nakahara Y., Sawada S., Nakagawa M. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost. 82:(5):1999;1516-1521.
100. Cox S.L., Trendelenburg A.U., Starke K. Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br J Pharmacol. 127:(5):1999;1256-1262.
101. Yang H.Y.T., Erdös E.G., Chiang T.S. New enzymatic route for the inactivation of angiotensin. Nature. 218:1968;1224-1226.
102. Santos R.A.S., Brum J.M., Brosnihan K.B., Ferrario C.M. The renin-angiotensin system during acute myocardial ischemia in dogs. Hypertension. 15:(Suppl I):1990;I121-I127.
103. Benter I.F., Diz D.I., Ferrario C.M. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension. 26:(2):1995;1138-1144.
104. Oliveira D.R., Santos R.A.S., Santos G.F.P., Khosla M.C., Campagnole-Santos M.J. Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension. 27:1996;1284-1290.
105. Britto R.R., Santos R.A.S., Fagundes-Moura C.R., Khosla M.C., Campagnole-Santos M.J. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension. 30:(2):1997;549-556.
106. Bomtempo C.A., Santos G.F., Santos R.A., Campagnole-Santos M.J. Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of heart rate. J Hypertens. 16:1998;1797-1804.
107. Gerken V.M.V., Santos R.A.S. Centrally infused bradykinin increases baroreceptor reflex sensitivity. Hypertension. 19:(Suppl II):1992;II176-II181.
108. Dampney R.A.L. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev. 74:(2):1994;323-364.
109. Sirret N.E., McLean A.S., Bray J.J., Hubbard J.I. Distribution of angiotensin II receptors in rat brain. Brain Res. 122:1977;299-312.
110. Song K., Allen A.M., Paxinos G., Mendelsohn F.A.O. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol. 316:1992;467-484.
111. Mendelsohn F.A.O., Quirion R., Saavedra J.M., Aguilera G. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci. 81:1984;1575-1579.
112. Casto R., Phillips M.I. Cardiovascular actions of microinjections of angiotensin II in the brain stem of rats. Am J Physiol. 246:1984;R811-R816.
113. Rettig R., Healy D.P., Printz M. Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii. Brain Res. 364:1986;233-240.
114. Casto R., Phillips M.I. Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats. Am J Physiol. 250:1986;R193-R198.
115. Campagnole-Santos M.J., Diz D.I., Ferrario C.M. Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension. 11:(Suppl I):1988;I167-I171.
116. Michelini L.C., Bonagamba L. Angiotensin II as a modulator of baroreceptor reflexes in the brainstem of conscious rats. Hypertension. 15:(Suppl 2):1990;I45-I50.
117. Barnes K.L., Knowles W.D., Ferrario C.M. Neuronal responses to angiotensin II in the in vitro slice from the canine medulla. Hypertension. 11:1988;680-684.
118. Campagnole-Santos M.J., Diz D.I., Ferrario C.M. Actions of angiotensin peptides after partial denervation of the solitary tract nucleus. Hypertension. 15:(Suppl I):1990;I34-I39.
119. Barnes K.L., Knowles W.D., Ferrario C.M. Angiotensin II and angiotensin-(1-7) excite neurons in the canine medulla in vitro. Brain Res Bull. 24:1990;275-280.
120. Chaves G.Z., Caligiorne S.M., Santos R.A.S., Khosla M.C., Campagnole-Santos M.J. Evidence that endogenous angiotensin-(1-7) participates in the modulation of the baroreflex at the nucleus tractus solitarii. Hypertension. 25:1995;1389. (Abstract).
121. Diz D.I., Ferrario C.M. Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin-(1-7). Raizada M.K., et al. Recent advances in cellular and molecular aspects of angiotensin receptors. 1996;225-235 Plenum Press, New York.
122. Andreatta S.H., Averill D.L., Santos R.A.S., Ferrario C.M. The ventrolateral medulla: a new site of action of the renin-angiotensin system. Hypertension. 11:1988;I163-I166.
123. Allen A.M., Dampney R.A.L., Mendelsohn F.A.O. Angiotensin receptor binding and pressor effect in cat subretrofacial nucleus. Am J Physiol. 255:1988;H1011-H1017.
124. Sasaki S., Dampney R.A.L. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension. 15:(3):1990;274-283.
125. Li Y.-W., Polson J.W., Dampney R.A.L. Angiotensin II excites vasomotor neurons but not respiratory neurons in the rostral and caudal ventrolateral medulla. Brain Res. 77:1992;161-164.
126. Mosqueda-Garcia R., Tseng C.-J., Appalsamy M., Robertson D. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats. J Pharmacol Exp Ther. 255:1990;374-381.
127. Muratani H., Averill D.B., Ferrario C.M. Effects of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol. 260:(29):1991;R977-R984.
128. Saigusa T., Head G.A. Renal sympathetic baroreflex effects of angiotensin II infusions into the rostral ventrolateral medulla of the rabbit. Clin Exp Pharmacol Physiol. 20:1993;351-354.
129. Sesoko S., Muratani H., Takishita S., Teruya H., Kawazoe N., Fukiyama K. Modulation of baroreflex function by angiotensin II endogenous to the caudal ventrolateral medulla. Brain Res. 671:1995;38-44.
130. Saigusa T., Iriki M., Arita J. Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla. Am J Physiol. 271:1996;H1015-1021.
131. Ito S., Sved A.F. Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone. Am J Physiol. 270:1996;R1317-1323.
132. Fontes M.A.P., Silva L.C.S., Campagnole-Santos M.J., Khosla M.C., Guertzenstein P.G., Santos R.A.S. Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptor. Brain Res. 665:(1):1994;175-180.
133. Fontes M.A.P., Martins Pinge M.C., Naves V., Campagnole-Santos M.J., Lopes O.U., Khosla M.C., Santos R.A.S. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res. 750:1997;305-310.
134. Santos R.A.S., Campagnole-Santos M.J., Baracho N.C.V., et al. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 35:(4):1994;293-298.
135. Averill D.B., Tsuchihashi T., Khosla M.C., Ferrario C.M. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res. 665:1994;245-252.
136. Hirooka Y., Potts P.D., Dampney R.A.L. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res. 772:1997;107-114.
137. 1 receptors in the central control of sympathetic vasomotor function. Clin. Exp. Pharmacol. Physiol. (Suppl 3):1996;S93-S98.
138. Lima D.X., Fontes M.A.P., Oliveira R.C., Campagnole-Santos M.J., Khosla M.C., Santos R.A.S. Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade. Immunopharmacology. 33:1996;305-307.
139. Mullins J.J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 344:1990;541-544.
140. Bader M., Lee M.A., Zhao Y., Bohm M., Bachmann J., Sander M., Djavidani B., Bachmann S., Zimmerman F., Wilbertz J., Zeh K., Wagner J., Peters J., Ganten D. Renin gene expression and hypertension in transgenic animals. Raizada M.K., Phillips M.I., Sumners C. Cellular and molecular biology of the renin-angiotensin system. 1993;60-72 CRC Press, London.
141. Lima D.X., Campagnole-Santos M.J., Fontes M.A.P., Khosla M.C., Santos R.A.S. Hemorrhage increases the pressor effect of angiotensin-(1-7) but not of angiotensin II at the rat ventrolateral medulla. J Hypertens. 17:1999;1145-1152.
142. Felix D., Khosla M.C., Imbodem H., Montani B., Ferrario C.M. Neurophysiological responses to angiotensin-(1-7). Hypertension. 17:1991;1111-1114.
143. Ambühl P., Felix D., Khosla M.C. [7-D-Ala]-Angiotensin-(1-7): selective antagonism of angiotensin-(1-7) in the rat paraventricular nucleus. Brain Res Bull. 35:(4):1994;289-291.
144. +-ATPase activity from basolateral membrane of the proximal tubule. Biochem Biophys Acta. 2000;. In press.
145. Dellipizzi A., Hilchey S.D., McGiff J.C., Bell-Quilley C.P. Renal actions of angiotensin-(1-7): comparison with angiotensin II. Pharmacologist. 34:1992;326.
146. Pawloski-Dahm C., Fink G.D. Chronic intravenous infusion of angiotensin-(1-7) produces increases in circulating vasopressin but not arterial pressure. Hypertension. 20:1992;69. (Abstract).
147. 2 activity and sodium transport by angiotensin-(1-7). Kidney Int. 44:1993;932-936.
148. Botelho L.M., Block C.H., Khosla M.C., Santos R.A.S. Plasma angiotensin-(1-7) levels is increased by water deprivation, salt load and hemorrhage. Peptides. 15:(4):1994;723-729.
149. Garcia N.H., Garvin J.L. Angiotensin-(1-7) has a biphasic effect on fluid absorption in the proximal straight tubule. J Am Soc Nephrol. 5:1994;1133-1138.
150. Farina M.D.D., Santos R.A.S., Lopes M.J. Angiotensin-(1-7) has a biphasic effect on frog (Rana catesbeiana) skin osmotic permeability. Hypertension. 25:(6):1995;1409. (Abstract).
151. Benter I.F., Ferrario C.M., Morris M., Diz D.I. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 269:1995;H313-H319.
152. 2 release. Hypertension. 25:1995;1238-1244.
153. Santos R.A.S., Simões e Silva A.C., Khosla M.C., Magaldi A.J., Passaglio K.T., Cesar K.R., Baracho N.C.V. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension. 27:1996;875-884.
154. Handa R.K., Ferrario C.M., Strandhoy J.W. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 270:1996;F141-F147.
155. 125I-Ang-(1-7) em rim de rato. 1999;Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. Thesis.
156. Heller J., Kramer H.J., Maly J., Cervenka L., Horacek V. Effect of intrarenal infusion of angiotensin-(1-7) in the dog. Kidney Blood Press Res. 23:(2):2000;89-94.
157. Heyne N., Beer W., Mühlbauer B., Osswald H. Renal response to angiotensin-(1-7) in anesthetized rats. Kidney Int. 47:1995;975-976. (Abstract).
158. Vallon V., Richter K., Heyne N., Osswald H. Effect of intratubular application of angiotensin-(1-7) on nephron function. Kidney Blood Press Res. 20:1997;233-239.
159. Simões e Silva A.C., Bello A.P.C., Baracho N.C., Khosla M.C., Santos R.A.S. Diuresis and natriuresis produced by long term administration of a selective angiotensin-(1-7) antagonist in normotensive and hypertensive rats. Regul Pept. 74:1998;177-184.
160. Block C.H., Santos R.A.S., Brosnihan K.B., Ferrario C.M. Immunocytochemical localization of angiotensin (1-7) in the rat forebrain. Peptides. 9:1988;1395-1401.
161. Calka J., Block C.H. Angiotensin-(1-7) and nitric oxide synthase in the hypothalamo-neurohypophysial system. Brain Res Bull. 30:1993;677-685.
162. Krob H.A., Vinsant H.L., Ferrario C.M., Friedman D.P. Angiotensin-(1-7) immunoreactivity in the hypothalamus of (mRen-2d)27 transgenic rat. Brain Res. 798:1998;36-45.
163. Moriguchi A., Ferrario C.M., Brosnihan K.B., Ganten D, Morris M. Differential regulation of central vasopressin in transgenic rats harbouring the mouse Ren-2 gene. Am J Physiol. 267:1994;R786-791.
164. Erdös E.G., Skiedgel R.A. Renal metabolism of angiotensin I and II. Kidney Int. 38:1990;24-27.
165. Senanayake P.S., Moriguchi A., Kumagai H., Ganten D., Ferrario C.M., Brosnihan K.B. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 15:(5):1994;919-926.
166. Ferrario C.M., Martell N., Yunis C., Flack J.M., Chappell M.C., Brosnihan K.B., Dean R.H., Fernandez A., Novikov S.V., Pinillas C., Luque M. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens. 11:1998;137-146.
167. Vallon V., Heyne N., Richter K., Khosla M.C., Fechter K. 7-D-Ala-angiotensin-(1-7) blocks renal actions of angiotensin-(1-7) in the anesthetized rat. J Cardiovasc Pharmacol. 32:(1):1998;164-167.
168. Paula R.D., Lima C.V., Khosla M.C., Santos R.A.S. Angiotensin-(1-7) potentates the hypotensive effects of bradykinin in conscious rats. Hypertension. 26:(2):1995;1154-1156.
169. Lima C.V., Paula R.D., Resende F.L., Khosla M.C., Santos R.A.S. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension. 30:(2):1997;542-548.
170. Hecker M., Blaukat A., Bara A.T., Müller-Esterl W., Busse R. ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br J Pharmacol. 121:1997;1475-1481.
171. Fernandes L., Fortes Z.B., Nigro D., Scivoletto R., Santos R.A.S., Carvalho M.H.C. Potentiation of bradykinin by angiotensin-(1-7) in mesenteric microvessels of spontaneously hypertensive rats. FASEB J. 14:(4):2000;A674. (Abstract).
172. Almeida A.P., Fábregas B.C., Madureira M.M., Santos R.J.S., Campagnole-Santos M.J., Santos R.A.S. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Braz J Mol Biol Med. 2000;. In press.
173. Jaiswal N., Diz D.I., Chappell M.C., Khosla M.C., Ferrario C.M. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension. 19:(Suppl II):1992;49-55.
174. Jaiswal N., Jaiswal R.K., Tallant E.A., Diz D.I., Ferrario C.M. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 21:1993;900-905.
175. Seyedi N., Xu X., Nasjletti A., Hintze T.H. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 26:1995;164-170.
176. Osei S.Y., Ahima R.S., Minkes R.K., Weaver J.P., Khosla M.C., Kadowitz P.J. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol. 234:1993;35-42.
177. Abbas A., Gorelik G., Carbini L.A., Scicli A.G. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension. 30:1997;217-221.
178. Oliveira M.A., Fortes Z.B., Santos R.A.S., Khosla M.C., Carvalho M.H.C. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilatation in vivo. Peptides. 20:1999;1195-1201.
179. Sasaki S., Higashi Y., Nakagawa K., Matsuura H., Kajiyama G., Oshima T. Angiotensin-(1-7) induced endothelium-independent vasodilation in normotensive control subjects and essential hypertensive patients. Circulation. 100:(Suppl S):2000;174. (Abstract).
180. Tran Y., Forster C. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol. 30:1997;676-682.
181. Mendes E.P., Vieira M.A.R., Santos R.A.S. Interaction between angiotensin-(1-7) and kinins in the renal hemodynamic. Proceedings of the III international symposium on vasoactive peptides, Belo Horizonte, MG, Brazil. 1999.
182. Widdop R.E., Sampey D.B., Jarrot B. Cardiovascular effects of
183. Meng W., Busija D.W. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke. 24:1993;2041-2045.
184. Ren Y., Garvin J.L., Carretero A.O. Receptor-mediated vasodilation effect of angiotensin 1-7 (Ang 1-7) in the isolated afferent arteriole (Af-Art). Am J Hypertens. 12:(4):1999;58A. (Abstract).
185. Nakamoto H., Ferrario C.M., Fuller S.B., Robaczewski D.L., Winicov E., Dean R.H. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 25:(2):1995;796-802.
186. Feterik K., Smith L., Katusic Z.S. Mechanisms of endothelium-dependent relaxation to angiotensin-(1-7) in canine femoral and middle cerebral arteries. Circulation. 100:(18):1999;2897. (Abstract).
187. Strawn W.B., Ferrario C.M., Tallant E.A. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension. 33:(2):1999;207-211.
188. Neves L.A.A., Almeida A.P., Khosla M.C., Campagnole-Santos M.J., Santos R.A.S. Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Braz J Med Biol Res. 30:1997;801-809.
189. van-Rodijnen W.F., van-Lambalgen T.A., van-Wijhe M.H., Tangelder G.-J., ter-Wee P.M. Angiotensin-(1-7) constricts renal microvessels in the isolated perfused hydronephrotic rat kidney preparation. Proceedings of American Society of Nephrology. 1999;A2339. (Abstract).
190. Kumagai H., Khosla M.C., Ferrario C.M., Fouad-Tarasi F.M. Biological activity of angiotensin-(1-7) heptapeptide in the hamster heart. Hypertension. 15:(Suppl I):1990;I29-I33.
191. Roks A.J., van-Geel P.P., Pinto Y.M., Buikema H., Henning R.H., deZeeuw D., van-Gilst W.H. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension. 34:(2):1999;296-301.
192. Ueda S., Masumori-Maemoto S., Ashino K., Nagahara T., Gotoh E., Umemura S., Ishii M. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension. 35:2000;998-1001.
193. Mahon J.M., Carrr R.D., Nicol A.K., Hendersn I.W. Angiotensin-(1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertens. 12:1994;1377-1381.
194. 1] angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists. J Med Chem. 32:1989;520-522.
195. Hanahan D., Folkman J. Patterns emerging of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
196. Sage E.H. Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol. 7:1997;182-186.
197. Fernandez L.A., Twickler J., Mead A. Neo-vascularization produced by angiotensin II. J Lab Clin Med. 105:1985;141-145.
198. Le Noble F.A.C., Hekking J.W., Van Straaten H.W.M., Slaaf D.W., Struyker-Boudier H.A.J. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol. 195:1991;305-306.
199. Hu D.E., Hiley C.R., Fan T.P. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelin-1 and -3 and angiotensin II in a rat sponge model. Br J Pharmacol. 117:(3):1996;545-551.
200. Andrade S.P., Cardoso C.C., Machado R.D.P., Beraldo W.T. Angiotensin-II-induced angiogenesis in sponge implants in mice. Int J Microcirc Clin Exp. 16:1996;302-307.
201. Tallant E.A., Lu X., Weiss R.B., Chappel M.C., Ferrario C.M. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 29:1997;388-393.
202. Neuß M., Rgitz-Zagrosek V., Hildebrandt A., Fleck E. Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation. Biochem Biophys Res Commun. 204:1994;1334-1339.
203. Nickening G., Geisen G., Vetter H., Sachinidis A. Characterization of angiotensin receptors on human skin fibroblasts. J Mol Med. 75:1997;217-222.
204. Machado R.D.P., Santos R.A.S., Andrade S.P. Angiotensin-(1-7)-induced inhibition of angiogenesis is prevented by specific receptor antagonist and by nitric oxide. 2000;P13 British Microcirculation Society, London. (Abstract).
205. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
206. Sakkoula E., Pipili-Synetos E., Maragoudakis E.M. Involvement of nitric oxide in inhibition of angiogenesis by interleukin-2. Br J Pharmacol. 122:1997;793-795.
207. Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler D., Kearney M., Couffinhal T., Isner J.M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Med. 3:1997;879-886.
208. Shirotani P., Yui Y., Hattori R., Kawai C. U-61431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells. Prostaglandins. 41:1991;97-100.
209. Nilsson J., Olsson A.G. Prostaglandin E inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis. 54:1984;77-82.
210. Feener E.P., King G.L. The biochemical and physiological characteristics of receptors. Adv Drug Del Rev. 29:1998;197-213.
211. Diz D.I., Pirro N.A.T. Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release. Hypertension. 19:1992;II41-II48.
212. Baracho N.C.V., Simões e Silva A.C., Khosla M.C., Santos R.A.S. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats. Braz J Med Biol Res. 31:1998;1221-1227.
213. Jaiswal N., Diz D.I., Tallant E.A., Khosla M.C., Ferrario C.M. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 260:1991;R1000-R1006.
214. Rowe B.P., Saylor D.L., Speth R.C., Absher D.R. Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain. Regul Pept. 56:(2-3):1995;139-146.
215. 2 receptor. Eur J Pharmacol. 343:1998;323-331.
216. 1b-type angiotensin receptors and novel nonangiotensin binding sites. Peptides. 14:1993;829-837.
217. Chansel D., Bizet T., Vandermeersch S., Pham P., Levy B., Ardaillou R. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am J Physiol. 266:(35):1994;F384-F393.
218. Li P., Ferrario C.M., Brosnihan K.B. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-I contractions in canine coronary arteries. J Pharmacol Exp Ther. 281:(3):1997;1065-1070.
219. Gironacci M.M., Coba M.P., Pena C. Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex. Regul Pept. 84:(1-3):1999;51-54.
220. Jaiswal N., Tallant E.A., Jaiswal R.K., Diz D.I., Ferrario C.M. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther. 265:1993;664-673.
221. Jaiswal N., Tallant E.A., Diz D.I., Khosla M.C., Ferrario C.M. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 17:(2):1991;1115-1120.
222. Carey R.M., Wang Z.-Q., Siragy H.M. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension. 35:(2):2000;155-163.
223. Zhou J., Ernsberger P., Douglas J.G. A novel angiotensin receptor subtype on rat mesangium: coupling to adenylyl cyclase. Hypertension. 21:1993;1035-1038.
224. Dendorfer A., Wolfrum S., Schäfer U., Stewart J.M., Inamura N., Dominiak P. Potentiation of the vascular responses to kinins by inhibition of myocardial kininases. Hypertension. 35:2000;32-37.
225. Textor S.C., Brunner H., Gavras H. Evidence for bradykinin potentiation by angiotensin congeners in conscious rats. Am J Physiol. 240:1981;H255-H261.
226. Salgado M.C.O., Krieger E.M. Acute changes in the renin-angiotensin system modify bradykinin and angiotensin reactivity and metabolism in conscious rats. Hypertension. 5:(Suppl V):1983;V172-V176.
227. Danser A.H.J., Vries R., Saxena P.R. Quinaprilat and angiotensin-(1-7) potentiate bradykinin-induced vasorelaxation via different mechanisms. Hypertension. 34:(1):1999;714. (Abstract).
228. Davie A.P., McMurray J.J. Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor. Hypertension. 34:(3):1999;457-460.
229. Stanziola L., Greene L.J., Santos R.A.S. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats. Am J Hypertens. 12:1999;1021-1029.
230. Pörsti I., Bara A.T., Busse R., Hecker M. Corrigendum. Br J Pharmacol. 117:1996;231.